Stephen Chan Lam
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| CXD101 in Immunotherapy-related Liver Cancer (NCT05873244) | Stephen Chan Lam | 2023-08-21 |
| Cabozantinib in Hepatocellular Carcinoma (NCT04588051) | Stephen Chan Lam | 2020-11-01 |
Track Stephen Chan Lam automatically
Every clearance here is in the API, with alerts when new ones post.